Enliven Therapeutics (ELVN) Q1 2022 Earnings

6MayExpected
Q2 2021
Q3 2021
Q4 2021
Q1 2022
-2.96
-2.16
-1.37
-0.57

Details

Expected EPS
-0.569
Actual EPS
-2.24
Surprise EPS
-1.67
Surprise Percent
+293.67%

Description

Enliven Therapeutics (ELVN) has reported earnings of -2.24 per share for Q1 2022.

0 Comments

Share your thoughts